Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient

• Conditions: Chronic Kidney Disease 5D

• Registration Number: NCT05339009
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-04
• Study Start: 2022-04-01
• Study First Submitted: 2022-04-13
• Study First Submitted QC: 2022-04-13
• Last Update Submitted: 2022-04-13
• Study First Posted: 2022-04-21
• Last Update Posted: 2022-04-21
• Primary Completion: 2022-12-31
• Study Completion: 2023-05-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relationship between bio-ADM level and vascular refilling rate	Day 1	The refilling rate will be assessed by the ratio of relative blood volume and UF max

Secondary Outcome Measures

Name	Time	Method
Bio-ADM value according to comorbidity factors	Day 1	Bio-ADM value according to comorbidity factors (diabetes, heart failure and low-grade inflammation)

Trial Locations

Locations (1)

UH Montpellier; 🇫🇷 Montpellier, France